Understanding the financial cost of cancer clinical trial participation.
Courtney P WilliamsLuqin DengNicole E CastonKathleen D GallagherRebekah AngoveMaria PisuAndres AzueroRebecca ArendGabrielle Betty RocquePublished in: Cancer medicine (2024)
Cancer clinical trial-related financial hardship, most often stemming from travel expenses, affected almost half of trial-enrolled patients. Interventions are needed to reduce adverse financial participation effects and potentially improve cancer clinical trial participation.
Keyphrases
- clinical trial
- papillary thyroid
- phase ii
- physical activity
- childhood cancer
- squamous cell
- study protocol
- phase iii
- open label
- end stage renal disease
- ejection fraction
- newly diagnosed
- lymph node metastasis
- healthcare
- prognostic factors
- squamous cell carcinoma
- randomized controlled trial
- chronic kidney disease
- affordable care act
- patient reported
- infectious diseases